Reuters logo
3 years ago
La Jolla Pharma's drug improves kidney function in mid-stage study
March 10, 2014 / 8:32 PM / 3 years ago

La Jolla Pharma's drug improves kidney function in mid-stage study

March 10 (Reuters) - La Jolla Pharmaceutical Co said its experimental drug to treat chronic kidney disease met the main goal of improving kidney function in a mid-stage study.

The company said a lower dose of the drug, codenamed GCS-100, showed an increase in the rate of blood filtering through the kidneys, compared with a placebo.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below